# FDA Inspection 1256189 - Shanghai Henlius Biopharmaceuticals Co., Ltd. - August 18, 2023

Source: https://www.keypedia.com/records/fda_inspections/shanghai-henlius-biopharmaceuticals-co-ltd/88cd0f4d-a1b9-4162-a430-0e8b5625323b
Source feed: FDA_Inspections

> FDA Inspection 1256189 for Shanghai Henlius Biopharmaceuticals Co., Ltd. on August 18, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1256189
- Company Name: Shanghai Henlius Biopharmaceuticals Co., Ltd.
- Inspection Date: 2023-08-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/shanghai-henlius-biopharmaceuticals-co-ltd/27f2ead3-2366-4479-aa2e-d9895581080b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c